Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
1:25PMiHub NewswireFeaturedElement79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update
9:26AMiHub NewswireFeaturedSouthern Silver Announces Updated PEA on Cerro Las Minitas: US$501M After-tax NPV5%; 21% IRR; 48 Month payback
06/11/20246:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
06/11/20246:00PMBusiness WireWalker & Dunlop Mourns Death of Long-Time Board Member, Michael MaloneNYSE:WDWalker & Dunlop Inc
06/11/20246:00PMGlobeNewswire Inc.Beamr Provides Oracle Cloud Infrastructure Customers with Ultra-Efficient, AI-ready Video Processing SolutionNASDAQ:BMRBeamr Imaging Ltd
06/11/20246:00PMGlobeNewswire Inc.The Keg Royalties Income Fund announces June 2024 cash distributionKEG-UN
06/11/20245:59PMPR Newswire (US)Industrial Turbocharger Market size is set to grow by USD 773.4 million from 2024-2028, Stringent emission regulations to boost the market growth, Technavio
06/11/20245:58PMBusiness WireEcho Announces Landmark Sale of Mineral and Royalty Interests in Permian and Anadarko Basins
06/11/20245:57PMBusiness WireDie Indy Autonomous Challenge präsentiert von Bridgestone kehrt im Juli 2024 zum Goodwood Festival of Speed zurück
06/11/20245:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MURFUMurphy Canyon Acquisition Corporation
06/11/20245:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSGSCSG Systems International Inc
06/11/20245:55PMBusiness WireThe Bancorp Welcomes Mark Tryniski to Its Board of DirectorsNASDAQ:TBBKBancorp Inc
06/11/20245:55PMBusiness WireThe Luskin Orthopaedic Institute for Children Announces $50 Million Estate Gift by Meyer & Renee Luskin at Annual Stand for Kids Gala
06/11/20245:55PMPR Newswire (Canada)CPRS MEMBERS HONOURED WITH MAJOR AWARDS AT NATIONAL CONFERENCE
06/11/20245:54PMPR Newswire (US)The CRE Finance Council Announces New Chairs for Industry Forums
06/11/20245:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSGSCSG Systems International Inc
06/11/20245:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MURFUMurphy Canyon Acquisition Corporation
06/11/20245:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSGSCSG Systems International Inc
06/11/20245:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DLRDigital Realty Trust Inc
06/11/20245:52PMBusiness WirePLAYSTUDIOS Purchases Shares Owned by MicrosoftNASDAQ:MYPSPLAYSTUDIOS Inc
06/11/20245:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSGSCSG Systems International Inc
06/11/20245:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
06/11/20245:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSGSCSG Systems International Inc
06/11/20245:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CWBCCommunity West Bancshares New
06/11/20245:48PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AVDXAvidXchange Holdings Inc
06/11/20245:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSGSCSG Systems International Inc
06/11/20245:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENPHEnphase Energy Inc
06/11/20245:47PMGlobeNewswire Inc.Ultragenyx and Mereo BioPharma Announce New Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Sustained Reductions in Fracture Rates Following Treatment with Setrusumab (UX143) in Patients with Osteogenesis Imperfecta (OI)NASDAQ:MREOMereo BioPharma Group PLC
06/11/20245:47PMGlobeNewswire Inc.Ultragenyx and Mereo BioPharma Announce New Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Sustained Reductions in Fracture Rates Following Treatment with Setrusumab (UX143) in Patients with Osteogenesis Imperfecta (OI)NASDAQ:RAREUltragenyx Pharmaceutical Inc
06/11/20245:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:VLDVelo3D Inc

Your Recent History

Delayed Upgrade Clock